Tag: Chemotherapy
Study Examines Effect of Cancer Treatment on COVID-19 Mortality
Highest 30-day mortality seen with cancer treatment one to three months before COVID-19 diagnosis
Lung Cancer Treatment Plans Changed Due to Pandemic
57 percent of patients receiving active treatment had at least one change in treatment plans
Few High-Grade Soft Tissue Sarcoma Patients Receive Chemo
Percentage of STS patients receiving chemo driven by factors such as tumor size, income, facility type
MASCC/ISOO Update Guidelines for Management of Mucositis
Topics include basic oral care, photobiomodulation therapy, cryotherapy, natural interventions
Adherence to Prophylaxis for EGFRi-Linked Rash Beneficial
Adherence to prophylaxis protocols tied to drop in interventions, toxicity-linked chemo interruptions
Good Diet May Cut Toxicity Risk in Treatment of Pediatric ALL
Greater intake of foods rich in antioxidants tied to lower rates of infection, mucositis during treatment
Rituximab + Chemo Ups Survival in Pediatric B-Cell Non-Hodgkin Lymphoma
Event-free survival significantly longer for children, teens with high-grade, high-risk disease
Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects
PFS longer in pancreatic ductal adenocarcinoma with versus without homologous recombination deficiency
Addition of Atezolizumab May Aid in Metastatic Urothelial Cancer
Phase 3 trial shows prolonged progression-free survival for atezolizumab plus platinum-based chemo
UGN-101 Active in Chemoablation of Upper Tract Urothelial Cancer
Fifty-nine percent of patients had complete response at four to six weeks after initial therapy
